| PC | Prostate cancer |
| TCRD | Taiwan Cancer Registry database |
| NCCN | National Comprehensive Cancer Network |
| PSA | Prostate-specific antigen; AUA, American Urological Association |
| ASTRO | American Society for Radiation Oncology |
| UIR | Unfavorable intermediate risk |
| RP | Radical prostatectomy; RT, radiotherapy |
| ADT | Androgen-deprivation therapy; RCT, randomized controlled trial |
| 3D-CRT | Three-dimensional conformal radiotherapy |
| IMRT | Intensity-modulated radiotherap |
| PSM | Propensity score matching |
| NHIRD | National health insurance research data |
| BF | Biochemical failure; LRR, locoregional recurrence |
| DM | Distant metastasis |
| ICD-9-CM | International Classification of Diseases, Ninth Revision, Clinical Modification |
| CCI | Charlson Comorbidity Index |
| OS | Overall survival |
| HR | Hazard ratio |
| EBRT | External-beam radiotherapy |
| CI | Confidence interval |
| BFS | Biochemical failure–free survival |
| aHR | Adjusted hazard ratio |